John Darmawan
Impact in
- Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Osteoarthritis Treatment and Mechanisms
- Systemic Lupus Erythematosus Research
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- Rheumatoid Arthritis Research and Therapies 6
- Systemic Lupus Erythematosus Research 3
- Spondyloarthritis Studies and Treatments 2
-
- Autoimmune and Inflammatory Disorders Research 4
- Co-authors
- Shun Le Chen (4 shared papers)Ren Chen (3 shared papers)R. D. Wigley (3 shared papers)Qing Yu Zeng (3 shared papers)Zheng Yu Xiao (3 shared papers)Jonathan Parker (1 shared paper)Syed Atiqul Haq (5 shared papers)Johannes J. Rasker (7 shared papers)
- Journals
- Clinical Rheumatology (1 paper)The Journal of Rheumatology (1 paper)International Journal of Technology Assessment in Health Care (1 paper)Arthritis Research & Therapy (1 paper)International Journal of Rheumatic Diseases (3 papers)
- Partner nations
- ChinaIndonesiaBangladesh
In The Last Decade
John Darmawan
18 papers receiving 889 citations
Peers
Comparison fields: 5 of 88
- Rheumatology 456
- Nephrology 111
- Rehabilitation 94
- Hematology 115
- Psychiatry and Mental health 113
Countries citing papers authored by John Darmawan
This map shows the geographic impact of John Darmawan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Darmawan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Darmawan more than expected).
Fields of papers citing papers by John Darmawan
This network shows the impact of papers produced by John Darmawan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Darmawan. The network helps show where John Darmawan may publish in the future.
Co-authors
The 25 scholars most cited alongside John Darmawan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 282 | |
| 2 | Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. | 2005 | 166 |
| 3 | Rheumatic disease in an Australian Aboriginal community in North Queensland, Australia. A WHO-ILAR COPCORD survey. | 2004 | 108 |
| 4 | Prevalence of the rheumatic diseases in urban Vietnam: a WHO-ILAR COPCORD study. | 2003 | 88 |
| 5 | Low prevalence of knee and back pain in southeast China; the Shantou COPCORD study. | 2004 | 59 |
| 6 | 2010 | 39 | |
| 7 | 2007 | 33 | |
| 8 | 1995 | 23 | |
| 9 | Risk factors associated with rheumatic complaints: a WHO-ILAR COPCORD study in Shantou, Southeast China. | 2005 | 22 |
| 10 | The effect of control and self-medication of chronic gout in a developing country. Outcome after 10 years. | 2003 | 22 |
| 11 | Characteristics of chronic gout in Northern Sulawesi, Indonesia. | 2006 | 20 |
| 12 | 2008 | 16 | |
| 13 | 2008 | 15 | |
| 14 | Reduced burden of disease and improved outcome of patients with rheumatoid factor positive rheumatoid arthritis compared with dropouts. A 10 year observational study. | 2003 | 10 |
| 15 | 1995 | 8 | |
| 16 | Excellent endpoints from step-down bridge combination therapy of 5 immunosuppressants in NSAID-refractory ankylosing spondylitis: 6 year international study in Asia - WHO-ILAR COPCORD stage II treatment of the autoimmune diseases. | 2006 | 6 |
| 17 | Ten-year radiographic outcome in patients with rheumatoid factor positive rheumatoid arthritis treated with aggressive immunosuppressive combination therapy. | 2004 | 4 |
| 18 | Ten years radiographic outcome of rheumafactor positive rheumatoid arthritis patients treated with aggressive low dose immunosuppressive combination therapy. | 2004 | 3 |
About John Darmawan
John Darmawan is a scholar working on Rheumatology, Hematology, Nephrology, Pathology and Forensic Medicine and Rehabilitation, having authored 18 papers that have together received 924 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (6 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Gout, Hyperuricemia, Uric Acid (3 papers), Systemic Lupus Erythematosus Research (3 papers), Spondyloarthritis Studies and Treatments (2 papers), Musculoskeletal Disorders and Rehabilitation (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Cytomegalovirus and herpesvirus research (1 paper). The work is most often cited by research in Rheumatology (456 citations), Nephrology (111 citations), Rehabilitation (94 citations), Hematology (115 citations) and Psychiatry and Mental health (113 citations). John Darmawan has collaborated with scholars based in China, Indonesia and Bangladesh. Frequent co-authors include Shun Le Chen, Ren Chen, R. D. Wigley, Qing Yu Zeng, Zheng Yu Xiao, Jonathan Parker, Syed Atiqul Haq, Johannes J. Rasker, Mohammad Tahir and Fazlur Rahman. Their work appears in journals such as Clinical Rheumatology, The Journal of Rheumatology, International Journal of Technology Assessment in Health Care, Arthritis Research & Therapy and International Journal of Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.